MRVI - Maravai LifeSciences Holdings, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $-0.07
|
Rev Est: $49.1M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$4.50
DETAILS
HIGH:
$4.50
LOW:
$4.50
MEDIAN:
$4.50
CONSENSUS:
$4.50
UPSIDE:
44.23%
Market Cap:
861.15M
Volume:
541,432
Avg Volume:
1,144,655
52 Week Range:
1.665-4.215
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.39
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
570
IPO Date:
2020-11-20
EPS (TTM):
-1.05
P/E Ratio:
-5.19
Revenue (TTM):
259.19M
Total Assets:
1.01B
Total Debt:
376.69M
Cash & Equiv:
322.40M
Rev Growth (5Y):
12.6%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-22.5%
Debt/Equity:
1.16
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.08 | $-0.06 | -33.3% | $41.6M | $49.1M | -15.1% |
| 2025-08-11 | $-0.08 | $-0.06 | -33.3% | $47.4M | $50.1M | -5.4% |
| 2025-05-12 | $-0.08 | $-0.07 | -14.3% | $46.9M | $44.0M | +6.5% |
| 2025-03-18 | $-0.06 | $-0.03 | -100.0% | $56.4M | $57.8M | -2.4% |
| 2024-11-07 | $-0.02 | $-0.01 | -150.0% | $65.2M | $56.6M | +15.1% |
| 2024-08-07 | $-0.08 | $-0.04 | -100.0% | $73.4M | $71.6M | +2.5% |
| 2024-05-08 | $-0.02 | $-0.02 | -21.4% | $64.2M | $60.5M | +6.0% |
| 2024-02-22 | $0.01 | $0.00 | +184.9% | $74.1M | $64.4M | +15.2% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 259.19M | 288.94M | 883.00M | 799.24M | 284.10M | 143.14M | 123.83M |
| Net Income | (144.85M) | (119.03M) | 220.21M | 182.04M | 76.89M | (8.49M) | (17.73M) |
| EPS | -1.05 | -0.90 | 1.67 | 1.59 | 7.43 | -0.05 | -0.20 |
| Total Assets | 1.01B | 1.49B | 2.28B | 1.92B | 1.27B | 577.80M | 539.68M |
| Total Debt | 376.69M | 610.97M | 585.26M | 575.22M | 590.78M | 390.20M | 339.89M |
| Cash & Equivalents | 322.40M | 574.96M | 632.14M | 551.27M | 236.18M | 24.70M | 21.87M |
| Operating Cash Flow | 7.46M | 126.22M | 535.98M | 368.57M | 152.19M | 24.11M | (186,000) |
| Free Cash Flow | (22.19M) | 60.67M | 518.89M | 353.72M | 126.78M | 6.97M | (3.80M) |
| FCF per Share | -0.16 | 0.46 | 3.94 | 3.08 | 1.31 | 0.07 | -0.04 |
| Book Value | 325.29M | 416.75M | 545.22M | 315.50M | 88.51M | 141.40M | 144.41M |
| Cash & ST Investments | 322.40M | 574.96M | 632.14M | 551.27M | 236.18M | 24.70M | 21.87M |
| ROC Equity | -0.45 | -0.29 | 0.40 | 0.58 | 0.87 | -0.06 | -0.12 |